Fuzz ... first of all, hope you (and all) have a fun and relaxing holiday weekend! I would also love for something exciting Tuesday morning, or otherwise soon. We "should" be about to begin dosing of apabetalone for P2 Covid patients. The P2 Covid/apabetalone open label "acid test" is just about upon us, a BIG 2-4 weeks coming.

Huge Covid therapeutic market opportunity and worldwide visibility potentially, with the possibility of revenues riding on it soon, and maybe a whole new view of apabetalone, epigenetics, RVX, and maybe even Don. With a BTD and BoM2 following that potentially glorious set up.

Let's hope the mice (and organoids), and Dr Hudson (and Don) are right, and Covid patients are dancing again within a week of dosing ... or something akin that scenario. 

June is going to be an important month for RVX, and investors, and possibly the world, one way or another. glta